Nav: Home

News from Dec. 16, 2014 Annals of Internal Medicine

December 15, 2014

1. Earlier detection could close the race gap on colon cancer deaths

Racial disparities in colon cancer survival rates may be explained by overall health at the time of diagnosis rather than differences in treatment received, according to a study published in Annals of Internal Medicine. Colon cancer is the fourth-most common cancer in the United States. Black patients have higher incidence of colon cancer than white patients and are more likely to die from the disease. Researchers sought to determine the extent to which differences in overall health at diagnosis or differences in treatment could explain this disparity in survival. A total of 7,677 black patients with colon cancer were sequentially matched with three groups of white patients. Patients were matched first by demographic characteristics, then presentation (overall health including tumor size and comorbid conditions), and then treatment. The researchers found that treatment differences accounted for only a very small percentage of the overall racial disparity in 5-year survival. Most of the disparity in survival is explained by poorer health of black patients at diagnosis, with black patients presenting with more advanced disease and more comorbid conditions.

Note: The URL for this story will be live when embargo lifts. For a PDF, please contact Megan Hanks. To interview the lead author, please contact Dana Weidig at weidigd@email.chop.edu or

267-426-6092.

2. Emphysema on CT an important independent risk factor for death

Emphysema-like lung found on computed tomography (CT) is associated with an increased risk for mortality among people without airflow obstruction or COPD, according to a study published in Annals of Internal Medicine. Emphysema was originally diagnosed on autopsy but is also a common "incidental" finding on chest CT done for other reasons. Reduced lung function is known to be associated with increased all-cause mortality and persons with COPD and CT-detected emphysema are known to have worse outcomes. However, the prognostic significance of emphysema on CT among patients without COPD is unknown. Researchers followed 2,965 patients who had no COPD on spirometry for six years. They found that emphysema-like lung assessed quantitatively on CT is associated with increased all-cause mortality and, therefore, is a clinically important finding.

Note: The URL will be live when the embargo lifts. For a PDF of the study, please contact Megan Hanks. To interview the lead author, please contact Lucky Tran at lt2549@columbia.edu or

212-305-3689.

3. Patient feelings about consent for use of personal medical data: It's complicated

The purpose for which personal medical data is being used may be just as important as consent, according to a survey published in Annals of Internal Medicine. Patient-level health information has substantial value across a range of uses and is becoming more widely available as use of electronic health records (EHR) increases. As such, there has been considerable debate about patient consent. Some argue that health data should not be used without consent and others argue that consent for every use is infeasible and that a blanket opt-in should be employed. The rationale is that patients may have some obligation to share information for socially beneficial purposes. Researchers surveyed 3,064 people to examine public support for secondary uses of electronic health information under different types of consent agreements. Survey participants were presented with hypothetical scenarios of different uses of patient data. For each scenario, the purpose for which data were used varied, as did the level of detail provided and whether consent was obtained. Responses were complex and indicate that obtaining consent is important, but the purpose of the use of health information is also important. The authors suggest that social value of the information being used may need to be emphasized.

A related commentary also published in Annals of Internal Medicine discusses the recent publication of a study conducted by Facebook without participant consent. The article examines the ethics of corporate research with regard to consent as more and more information is shared online.

Note: The URL will be live when the embargo lifts. For a PDF, please contact Megan Hanks. To interview the lead author of the survey article, please contact Anna Duerr at anna.duerr@uphs.upenn.edu or 215-349-8369. To reach the lead author of the commentary, please contact Lucky Tran at lt2549@columbia.edu or 212-305-3689.
-end-


American College of Physicians

Related Colon Cancer Articles:

New model could speed up colon cancer research
Using the CRISPR gene editing system, MIT researchers have shown they can generate colon tumors in mice that very closely resemble human colon tumors, an advance that should allow scientists to learn more about how the disease progresses and also help them test potential new drugs.
Are dialysis patients being over-screened for colon cancer?
Colonoscopies are being performed more often on healthier dialysis patients than on those with more limited life expectancies; however, overall, dialysis patients are being screened at a much higher rate relative to their life expectancy than their counterparts without kidney failure.
The importance of the glutamine metabolism in colon cancer
The importance of glutamine was made clear as a colon cancer specific metabolism.
Discovery of a novel gene for hereditary colon cancer
The formation of large numbers of polyps in the colon has a high probability of developing into colon cancer, if left untreated.
How diet influences colon cancer
A study ties high-fat diet to changes in intestinal stem cells and may help explain increased cancer risk.
How gut inflammation sparks colon cancer
Duke biomedical engineers have shown how colon cancer development is intricately linked to a specific microRNA that dictates how cells divide.
Treating colon cancer with vitamin A
Scientists at EPFL have identified the biological pathway behind the growth of colon cancer, and were able block it with vitamin A.
More precise colon cancer screening?
A clinical scoring system for colon cancer risk could help physicians identify which average-risk patients could potentially skip a colonoscopy and instead be screened with a less-invasive method.
Testosterone may contribute to colon cancer tumor growth
James Amos-Landgraf, an assistant professor of veterinary pathobiology in the MU College of Veterinary Medicine, found evidence suggesting that the male hormone testosterone may actually be a contributing factor in the formation of colon cancer tumors.
Hormone loss could be involved in colon cancer
Like diabetes, colon cancer may be caused in part by the loss of one hormone, suggesting hormone replacement therapy could stall cancer formation.

Related Colon Cancer Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Climate Crisis
There's no greater threat to humanity than climate change. What can we do to stop the worst consequences? This hour, TED speakers explore how we can save our planet and whether we can do it in time. Guests include climate activist Greta Thunberg, chemical engineer Jennifer Wilcox, research scientist Sean Davis, food innovator Bruce Friedrich, and psychologist Per Espen Stoknes.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...